Jennifer Riley - Chief Strategy Officer at Avalo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Strategy Officer
Issuer Symbol
AVTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jennifer Riley since 13 Jan 2025

Holdings reported by Jennifer Riley for Avalo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,655 $10,885 $4.10 10 Dec 2025 Direct
Stock Option (Right to Buy) 150,000 01 Jan 2025 Direct Common Stock

Transactions reported by Jennifer Riley for Avalo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.